Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine during ECT for depression
NL-OMON27602Recruiting
- Sponsor
- Parnassia Groep
- Start
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of memantine in major depressive disorder (MDD) and bipolar disorder (BD) (2 arms), sponsored by Parnassia Groep. Primary endpoint: Cognitive test battery scores. Started Dec 2012; status: recruiting.
02
Drugs
memantine
03
Conditions
major depressive disorder (MDD)bipolar disorder (BD)
Beyond the preview
Go deeper on NL-OMON27602.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON27602.